BML, Inc. (TYO:4694)
4,075.00
-50.00 (-1.21%)
Feb 16, 2026, 3:30 PM JST
BML, Inc. Revenue
BML, Inc. had revenue of 38.85B JPY in the quarter ending December 31, 2025, with 4.41% growth. This brings the company's revenue in the last twelve months to 149.09B, up 5.49% year-over-year. In the fiscal year ending March 31, 2025, BML, Inc. had annual revenue of 143.19B with 3.79% growth.
Revenue (ttm)
149.09B
Revenue Growth
+5.49%
P/S Ratio
1.02
Revenue / Employee
32.71M
Employees
4,558
Market Cap
152.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 143.19B | 5.23B | 3.79% |
| Mar 31, 2024 | 137.96B | -21.50B | -13.48% |
| Mar 31, 2023 | 159.46B | -26.61B | -14.30% |
| Mar 31, 2022 | 186.07B | 47.50B | 34.28% |
| Mar 31, 2021 | 138.57B | 17.84B | 14.78% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.46T |
| Otsuka Holdings | 2.42T |
| Chugai Pharmaceutical | 1.26T |
| HOYA Corporation | 915.21B |
| Genky DrugStores | 211.29B |
| AS ONE | 107.59B |
| Kaken Pharmaceutical | 75.66B |
| SMS Co., Ltd. | 63.41B |